3 severity, as well as with within-household Spn transmission 5, [9] [10] [11] . The mechanisms and markers 47 associated with this pathogen synergy have been difficult to study in human subjects due to the 48 rapid nature of the disease.
49
One safe way to simulate influenza infection in the nose is using Live Attenuated Influenza Vaccine
50
(LAIV), consisting of cold-adapted influenza viruses. LAIV has been shown to affect the 51 subsequent susceptibility to Spn and to lead to increased carriage density in murine models of 52 infection and in vaccinated children 12, 13 . In a randomised controlled trial, we showed that LAIV 53 administration prior to Spn challenge led to 50% increase in Spn acquisition by molecular methods 54 as well as 10-fold increase in nasopharyngeal bacterial load 14 .
55
In murine models of pneumococcal carriage, Th17-dependent recruitment of neutrophils and 56 monocytes to the nasopharynx mediates immunological control and clearance [15] [16] [17] . Influenza virus 57 infection promotes Type I interferons which interfere with recruitment of these phagocytes, while 
63
In recent years, systems biology approaches have allowed for the identification of immune 64 mechanisms associated with protection from infectious diseases and with robust immune 65 responses during vaccination [22] [23] [24] [25] [26] [27] [28] . 
82
determined by classical microbiology (Fig 1a) . To investigate whether LAIV-induced immune
83
responses were associated with a predisposition to pneumococcal carriage, we measured levels of 84 30 cytokines in nasal lining fluid (Fig 1b) . At day 0, directly prior to Spn inoculation, LAIV
85
significantly increased levels of twenty cytokines after multiple testing correction, including IP-10,
86
TNF-α, IL-10, IFN-and IL-15 (Fig 1b and Table S1 ). In contrast, the control group did not show 87 any significant increase in cytokine response at day 0. Following Spn inoculation, Spn carriage in 88 the absence of LAIV was associated with increased levels of EGF at day 2 (p = 0.023) and 89 decreased levels of IL-1RA at day 9 post Spn inoculation (p = 0.027) compared to baseline, neither
90
of which remained significant after multiple testing correction. No other cytokines, including IL-17A
91
or MCP-1, were significantly altered by carriage alone (Fig 1b) .
92
Even before bacterial inoculation, nasal inflammatory responses to LAIV differed between those 93 who went on to become carrier and those who were protected from carriage (Fig 1c) . In particular,
94
IL-10 was increased more in LAIV-vaccinated subjects who did not acquire Spn following 95 inoculation (5.8-fold increase, p = 0.0097) than in those who became carriers following inoculation
96
(2.0-fold increase, p = 0.073). In contrast, IP-10 was increased more in subjects who went on to 97 5 become carriers (2.4-fold increase, p = 0.0008) than in those who remained carriage-negative (1.5-
98
fold increase, p = 0.051). Moreover, subjects with increased levels of IP-10 before inoculation 99 displayed higher pneumococcal density following Spn inoculation (Fig 1d) . This suggests that 100 differences in the response to influenza virus are associated with secondary susceptibility to Spn.
101
To test whether this was specific for LAIV infection, we measured IP-10 in nasal washes from an 102 independent cohort in which a subset of subjects had asymptomatic 
111
Early neutrophil degranulation in response to carriage is impaired by LAIV infection
112
In murine models, neutrophil recruitment after onset of carriage contributes to control of the 113 bacteria 15 . We observed pre-existent high levels of neutrophils in the human nose and 114 pneumococcal carriage did not lead to significant further recruitment of neutrophils (Fig S3a,b) (Fig 2a) . This neutrophil activation was impaired in the LAIV group, who displayed high 119 carriage density during early carriage and had increased acquisition compared to controls.
120
Together, this suggests that neutrophil degranulation is important for the initial control of carriage.
121
To investigate whether neutrophils were also impaired systemically following LAIV as reported
122
during wild-type influenza infection
32
, we isolated blood neutrophils before, and at three days after,
6
LAIV administration from a subset of subjects. We confirmed that opsonophagocytic killing of Spn 124 by blood neutrophils was decreased following LAIV (Fig 2b, 
126
decreasing killing capacity in a dose-dependent manner (Fig 2c,d ). Nanostring expression analysis
127
of 594 genes revealed 10 differentially expressed genes in blood neutrophils 3 days post LAIV
128
( (Fig 3a,b) . Moreover, peak pneumococcal density associated with increased monocyte 143 recruitment in the control group (r=0.51, p=0.02), but not the LAIV group (r=0.08, p=0.70; Fig 3c,d ).
144
Indeed, for subjects in the control group with very low carriage densities, which were only 145 detectable by molecular methods, no monocyte recruitment was observed (Fig S4c) . This suggests 146 that a minimum Spn load is required for sensing and monocyte recruitment and that LAIV infection 147 interferes with this process. While MCP-1 was not significantly induced following Spn carriage,
148
levels correlated with numbers of monocytes at all timepoints (Fig S5a) . Furthermore, stratification 7 of individuals showed that those with increased MCP-1 levels at day 2 post Spn inoculation exhibit 150 increased monocyte recruitment (Fig S5b) . Levels of IL-6, IFN-γ and TNF-α also correlated with 151 levels of monocytes at each time point, but stratification of individuals did not reveal a differential 152 recruitment of monocytes (Fig S5a,b) . In a second, independent cohort that did not receive any 153 vaccine, monocytes were increased at day 9 following Spn inoculation, which correlated with
154
increased MCP-1 levels in nasal fluid, validating these results (Table S3 and Fig S5c) .
155
Nasal responses associated with pneumococcal clearance are impaired by LAIV
156
To assess anti-pneumococcal responses induced by carriage, we collected nasal cells 29 days 
159
TNF-α, MIP-1α, IL-10, IL-6 and GM-CSF upon restimulation was observed in the control carriage+ 160 group (Fig 4a and Fig S6a) . In the LAIV carriage+ group, however, this boosting of anti-
161
pneumococcal cytokine responses by re-challenge was absent (Fig 4a and Fig S6a) . The 162 production of the above five cytokines correlated with decreased density at day 29 post Spn
163
inoculation, suggesting these responses are involved in Spn clearance (Fig 4b) . To test whether 164 monocytes/macrophages were the source of these cytokines we compared the cytokine signature
165
from whole nasal cells with that from alveolar macrophages exposed to Spn in vitro (Fig 4c) .
166
Relative cytokine production highly correlated (r = 0.66, p < 0. 
180
In the LAIV carriage+ group, 936 and 711 DEG were observed at day 2 and day 9, respectively.
181 Surprisingly, despite the high levels of inflammatory cytokines observed in the LAIV carriage-182 group, only a relatively small number of DEG were observed at days 2 and 9 (126 and 153, 183 respectively). DEG of carriage+ subjects receiving LAIV and DEG of carriage+ without LAIV
184
showed very little overlap with only 38 DEG at day 2 and 2 DEG at day 9 in common. Very little
185
overlap was also observed on the pathway level between these groups, indicating LAIV alters the 186 natural responses to pneumococcus (Fig 5b and Table S5 ). This could reflect transcriptome 187 kinetics, such as observed in altered differentiation and cellular activation, or changes in cell 188 migration to the nasal mucosa.
189
The LAIV carriage+ group showed an enrichment for genes in TLR3 signalling cascade, RIG- organization" and "collagen formation" (Fig S7) .
10
For LAIV, we identified six distinct co-expression modules (Supp html file 2), which were strongly 226 enriched in genes related to "Diseases associated with O-glycosylation of proteins" (module M1),
227
"Immunoregulatory interactions between a lymphoid and a non-Lymphoid cell" (module M3),
228
"chemokine receptors bind chemokines" (module M4), as well as "interferon signalling" (module
229
M5, Fig S8) . 
245
In addition, our findings that LAIV led to impaired blood neutrophil killing capacity and that the 
11
We identified IP-10 as a marker for increased susceptibility to Spn and propose this should be 
264
contrary to key mechanisms described in murine models, we did not observe any production of IL-
265
17A or neutrophil recruitment to the nose following carriage or associated with carriage clearance 266 15-17 , underlining the importance of confirmation of murine findings by human data.
267
One limitation of this study is that only one pneumococcal serotype 6B isolate was used, future 268 studies using other isolates with a more or less invasive phenotype will be able to answer how 269 generalizable these findings across pneumococcal isolates are. Nonetheless, the observation that 270 carriage density and duration declines in parallel for all serotypes following repeated exposure,
271
suggests that immunological control of newly-acquired Spn is mediated by similar mechanisms 272 independent of the colonizing serotype 49 .
273
In conclusion, this study highlighted the importance for innate immunity in the control of carriage 274 density and clearance of Spn, which was impaired by pre-existing viral infections (Fig S9) .
275
Secondary bacterial infection following viral respiratory tract infection has a large burden of 12 disease worldwide and disrupting viral-bacterial synergy through host-directed therapy could prove
277
an attractive addition to current therapeutic and vaccination options 50 .
278

Methods
279
Study design and sample collection scanned on a nCounter® MAX (Nanostring). Raw counts were analysed using DESeq2 using 360 internal normalization, which gave lower variance than normalizing to included housekeeping 361 genes. DEG were identified using a model matrix correcting for repeated individual measurements.
362
Log counts per million (CPM) from raw counts were calculated using the 'edgeR' package.
363
RNA sequencing analysis
364
Quality control of raw sequencing data was done using fastQC. Mapping to a human reference 365 genome assembly (GRCh38) was done using STAR 2.5.0a 55 . Read counts from the resulting
366
BAM alignment files were obtained with featureCounts using a GTF gene annotation from the
367
Ensembl database 56,57 . The R/Bioconductor package DESeq2 was used to identify differentially 368 expressed genes among the samples, after removing absent features (zero counts in more than 369 75% of samples) 58 . Genes with an FDR value < 0.1 and an absolute fold change (FC) > 1.5 were 370 identified as differentially expressed.
371
Co-expression analysis
372
For co-expression analysis, counts were normalized using log CPM and the log2 fold change was 373 calculated for each time point in a subject-wise manner. 
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